Manufacturing

The delicate balance between cutting-edge biological innovation and the cold reality of fiscal responsibility determines the ultimate success of modern bioprocessing facilities operating in today's high-stakes market. While the technical sophistication of a laboratory often garners the most

The traditional method of identifying unknown chemicals in medical devices has relied on a precarious game of structural "look-alikes" that often misses the mark by an order of magnitude. In pharmaceutical and medical device manufacturing, ensuring that products are free from harmful Extractables

Ivan Kairatov is a seasoned veteran in biopharmaceutical research and development, having spent nearly two decades navigating the complex intersection of molecular biology and clinical strategy. With a deep specialization in small molecule innovation and a career dedicated to the evolution of

The landscape of neuro-pediatrics shifted significantly when medical professionals successfully administered a groundbreaking gene replacement therapy to an infant suffering from a rare, terminal genetic condition. This procedure, performed at the Schneider Children's Medical Center, targeted

The precision of modern surgical intervention has reached a point where the traditional "one size fits all" approach to medical implants is no longer a viable standard for high-stakes procedures. At the Levin Center for Surgical Innovation and 3D Printing, located within the Ichilov Medical Center,

The biopharmaceutical industry is currently witnessing a transformative shift toward extreme process intensification, where the drive for higher volumetric productivity is pushing cellular densities to unprecedented levels. In the quest to minimize the physical footprint of manufacturing facilities